We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

162 hedge funds and large institutions have $1.23B invested in Aerie Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,450% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 4

300% more funds holding in top 10

Funds holding in top 10: 2 → 8 (+6)

151% more capital invested

Capital invested by funds: $489M → $1.23B (+$737M)

56% more funds holding

Funds holding: 104 → 162 (+58)

40% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 35

29% more call options, than puts

Call options by funds: $34.6M | Put options by funds: $26.8M

Holders
162
Holders Change
+58
Holders Change %
+55.77%
% of All Funds
4.32%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.21%
New
62
Increased
49
Reduced
35
Closed
4
Calls
$34.6M
Puts
$26.8M
Net Calls
+$7.76M
Net Calls Change
+$3.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17.6M
2
FCMI
Foresite Capital Management II
California
+$15.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$12.3M
4
ACA
Avoro Capital Advisors
New York
+$11M
5
Ameriprise
Ameriprise
Minnesota
+$9.67M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$26.1M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.91M
3
PHS
PFM Health Sciences
California
-$8.27M
4
NC
Northpointe Capital
Michigan
-$4.54M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$4.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
FC
101
Financial Consulate
Maryland
$755K – – –
Simplex Trading
102
Simplex Trading
Illinois
$754K +$430K +19,477 +3,812%
ProShare Advisors
103
ProShare Advisors
Maryland
$753K -$60.6K -2,746 -12%
Neuberger Berman Group
104
Neuberger Berman Group
New York
$698K +$408K +18,500 New
MLICM
105
Metropolitan Life Insurance Company (MetLife)
New York
$675K – – –
Citigroup
106
Citigroup
New York
$656K +$167K +7,557 +77%
Tudor Investment Corp
107
Tudor Investment Corp
Connecticut
$641K +$375K +16,990 New
Manulife (Manufacturers Life Insurance)
108
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$637K -$3.35K -152 -0.9%
FO
109
FT Options
Illinois
$628K +$367K +16,630 New
GAMA
110
Graticule Asia Macro Advisors
New York
$604K +$353K +16,000 New
DekaBank Deutsche Girozentrale
111
DekaBank Deutsche Girozentrale
Germany
$599K – – –
N
112
Nuveen
North Carolina
$585K +$342K +15,502 New
Squarepoint
113
Squarepoint
New York
$568K +$332K +15,043 New
Wells Fargo
114
Wells Fargo
California
$561K +$58.9K +2,669 +22%
WA
115
Wasatch Advisors
Utah
$546K -$7.59K -344 -2%
AIG
116
American International Group
New York
$524K +$463 +21 +0.2%
BA
117
BlackRock Advisors
Delaware
$492K +$16.1K +730 +6%
PIA
118
Phoenix Investment Adviser
New York
$472K +$276K +12,500 New
CG
119
Colony Group
Massachusetts
$448K – – –
UBS AM
120
UBS AM
Illinois
$442K +$258K +11,700 New
RJFSA
121
Raymond James Financial Services Advisors
Florida
$433K +$253K +11,474 New
QSS
122
Quantitative Systematic Strategies
Florida
$320K +$187K +8,485 New
GBBWRPM
123
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$307K – – –
BG
124
BlackRock Group
United Kingdom
$304K +$7.87K +357 +5%
ARTA
125
A.R.T. Advisors
New York
$298K -$639K -28,967 -79%
3 4
5
6 7

AERI Hedge Fund Activity: Q3 2016 in Review

162 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2016, worth a combined $1.23B — up 151% from $489M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new AERI positions and 4 closed out — a net gain of 58 holders — while 49 added to existing stakes and 35 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $17.6M. The largest seller was Deerfield Management, cutting an estimated $26.1M.

  • 162 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $1.23B of Aerie Pharmaceuticals stock for Q3 2016, up 151% quarter-over-quarter.
  • 62 funds opened new Aerie Pharmaceuticals positions in Q3 2016 and 4 closed out, a net change of +58 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2016 was OrbiMed, an estimated $17.6M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2016 was Deerfield Management, an estimated $26.1M sold.

Based on aggregated 13F filings for Q3 2016.